Keith Grehan

522 total citations
14 papers, 301 citations indexed

About

Keith Grehan is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Keith Grehan has authored 14 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Keith Grehan's work include Viral gastroenteritis research and epidemiology (10 papers), Viral Infections and Immunology Research (8 papers) and Virus-based gene therapy research (5 papers). Keith Grehan is often cited by papers focused on Viral gastroenteritis research and epidemiology (10 papers), Viral Infections and Immunology Research (8 papers) and Virus-based gene therapy research (5 papers). Keith Grehan collaborates with scholars based in United Kingdom, United States and Saudi Arabia. Keith Grehan's co-authors include Nigel Temperton, Francesca Ferrara, Craig Thompson, George Carnell, George M. Warimwe, Naif Khalaf Alharbi, Teresa Lambe, Stephan Becker, Sarah C. Gilbert and Eriko Padron-Regalado and has published in prestigious journals such as Frontiers in Immunology, PLoS Pathogens and Journal of General Virology.

In The Last Decade

Keith Grehan

13 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Grehan United Kingdom 8 227 80 73 50 48 14 301
Tarka Raj Bhatta Australia 7 244 1.1× 69 0.9× 73 1.0× 36 0.7× 18 0.4× 9 326
Brandi Livingston United States 9 165 0.7× 170 2.1× 57 0.8× 54 1.1× 28 0.6× 19 350
Jane K. Fieldhouse United States 9 143 0.6× 150 1.9× 43 0.6× 54 1.1× 27 0.6× 12 288
Zhengchun Lu United States 11 210 0.9× 100 1.3× 183 2.5× 78 1.6× 106 2.2× 20 393
Meiniang Wang China 7 200 0.9× 34 0.4× 97 1.3× 31 0.6× 17 0.4× 13 307
Nazia Thakur United Kingdom 11 213 0.9× 95 1.2× 53 0.7× 22 0.4× 9 0.2× 18 288
Han Di United States 10 133 0.6× 85 1.1× 83 1.1× 31 0.6× 29 0.6× 18 229
Lorena Sánchez-Felipe Belgium 9 149 0.7× 104 1.3× 53 0.7× 40 0.8× 15 0.3× 15 336
Xianfeng Hui China 7 363 1.6× 37 0.5× 177 2.4× 39 0.8× 13 0.3× 17 423
Lee Sherry United Kingdom 8 132 0.6× 61 0.8× 27 0.4× 34 0.7× 124 2.6× 18 268

Countries citing papers authored by Keith Grehan

Since Specialization
Citations

This map shows the geographic impact of Keith Grehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Grehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Grehan more than expected).

Fields of papers citing papers by Keith Grehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Grehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Grehan. The network helps show where Keith Grehan may publish in the future.

Co-authorship network of co-authors of Keith Grehan

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Grehan. A scholar is included among the top collaborators of Keith Grehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Grehan. Keith Grehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sherry, Lee, Keith Grehan, Mohammad W. Bahar, et al.. (2025). Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation. npj Vaccines. 10(1). 64–64.
2.
Grehan, Keith, Stephen J. Polyak, David J. Filman, et al.. (2024). Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate. PLoS Pathogens. 20(9). e1012511–e1012511. 2 indexed citations
3.
Grehan, Keith, Mark Hassall, Guido C. Paesen, et al.. (2023). VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display. mSphere. 8(1). e0056822–e0056822. 3 indexed citations
4.
Martyna, Agnieszka, Keith Grehan, Helen Fox, et al.. (2023). Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate. Journal of General Virology. 104(6). 9 indexed citations
5.
Sherry, Lee, Keith Grehan, Mohammad W. Bahar, et al.. (2022). Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris. Viruses. 14(10). 2159–2159. 7 indexed citations
6.
Bahar, Mohammad W., Veronica Nasta, Helen Fox, et al.. (2022). A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Communications Biology. 5(1). 1293–1293. 5 indexed citations
8.
Grehan, Keith, et al.. (2022). Development of an Enzyme-Linked Immunosorbent Assay for Detection of the Native Conformation of Enterovirus A71. mSphere. 7(3). e0008822–e0008822. 5 indexed citations
9.
Sherry, Lee, Keith Grehan, Michael L. Knight, et al.. (2020). Comparative Molecular Biology Approaches for the Production of Poliovirus Virus-Like Particles Using Pichia pastoris. mSphere. 5(2). 25 indexed citations
10.
Carnell, George, Keith Grehan, Francesca Ferrara, Eleonora Molesti, & Nigel Temperton. (2017). An Optimized Method for the Production Using PEI, Titration and Neutralization of SARS-CoV Spike Luciferase Pseudotypes. BIO-PROTOCOL. 7(16). e2514–e2514. 12 indexed citations
11.
Alharbi, Naif Khalaf, Eriko Padron-Regalado, Craig Thompson, et al.. (2017). ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Vaccine. 35(30). 3780–3788. 113 indexed citations
12.
Grehan, Keith, Francesca Ferrara, & Nigel Temperton. (2015). An optimised method for the production of MERS-CoV spike expressing viral pseudotypes. MethodsX. 2. 379–384. 43 indexed citations
13.
Carnell, George, Francesca Ferrara, Keith Grehan, Craig Thompson, & Nigel Temperton. (2015). Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis. Frontiers in Immunology. 6. 161–161. 59 indexed citations
14.
Temperton, Nigel, Keith Grehan, Simon D. Scott, et al.. (2015). Technical Considerations for the Generation of Novel Pseudotyped Viruses. Future Virology. 11(1). 47–59. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026